teniposide

DRUG9 trials

Conditions

Acute Lymphoblastic LeukemiaAdult Acute Lymphocytic LeukemiaHLHLeukemiaLymphomaPrimary Central Nervous System LymphomaRecurrent B-Cell Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood B-Lymphoblastic Lymphoma

Phase 1

Ifosfamide, Teniposide, and Paclitaxel in Treating Patients With Relapsed Non-Hodgkin's Lymphoma

CompletedNCT00004916

Northwestern UniversityLymphoma

Start: 1999-02-28End: 2002-10-31Updated: 2012-06-06

Phase 2

Combination Chemotherapy, Bone Marrow or Peripheral Stem Cell Transplantation, and/or Biological Therapy in Treating Patients With Stage III or Stage IV Mantle Cell Lymphoma

CompletedNCT00004231

Northwestern UniversityLymphoma

Start: 1999-10-31End: 2006-08-31Updated: 2012-06-06

Combination Chemotherapy in Treating Adults With Acute Lymphocytic Leukemia

NCT00002531

Johann Wolfgang Goethe University HospitalLeukemia

Start: 1993-01-31Updated: 2013-09-17

Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma

CompletedNCT01700946

St. Jude Children's Research HospitalRecurrent B-Cell Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood B-Lymphoblastic Lymphoma

Start: 2013-04-15End: 2021-07-24Updated: 2022-09-28

Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL

Not yet recruitingNCT07185373

Huashan HospitalPrimary Central Nervous System Lymphoma

Start: 2025-10-01End: 2029-07-30Target: 215Updated: 2025-09-22

Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)

CompletedNCT00198991

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 2003-04-30End: 2013-06-30Updated: 2022-08-18

Treatment of High Risk Adult Acute Lymphoblastic Leukemia

CompletedNCT00853008

PETHEMA FoundationAcute Lymphoblastic Leukemia

Start: 2003-01-31End: 2012-12-31Target: 100Updated: 2020-04-07

Unknown Phase

Combination Chemotherapy in Treating Young Patients With Acute Lymphoblastic Leukemia

NCT00343369

Universitätsklinikum Hamburg-EppendorfLeukemia

Start: 2003-01-31Target: 550Updated: 2013-08-26

Teniposide Incorporating Bu/Cy Conditioning Regimen for HLH With Central Nervous System Involvemen

NCT06048107

Beijing Friendship HospitalHLH

Start: 2023-10-22End: 2025-09-30Target: 20Updated: 2023-11-02

Blood2020-11-04

Characteristics and Outcome of Early T Cell Precursor ALL (ETP-ALL) Patients Treated with High-Risk Spanish Pethema Protocols

Blood2018-11-29

Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have <i>IGH-CRLF2</i> and <i>JAK2</i> mutations, persistence of minimal residual disease and poor prognosis

Haematologica2016-08-25161 citations

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.

2012-09-28342 citations

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

2012-03-22349 citations